Oral Metronomic Maintenance Therapy Can Improve Survival in High-Risk Neuroblastoma Patients Not Treated with ASCT or Anti-GD2 Antibodies

SIMPLE SUMMARY: Low-dose metronomic chemotherapy has anti-angiogenic activity and inhibits tumor growth. Therefore, we investigated the benefits of low-dose metronomic maintenance therapy (MT) in high-risk neuroblastoma (NB) patients who are unable to undergo autologous stem cell transplantation (AS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Sun, Xiaofei, Zhen, Zijun, Guo, Ying, Gao, Yuanhong, Wang, Juan, Zhang, Yu, Zhu, Jia, Lu, Suying, Sun, Feifei, Huang, Junting, Cai, Ruiqing, Zhang, Yizhuo, Liu, Juncheng, Xiao, Zizheng, Zeng, Sihui, Liu, Zhuowei
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8303783/
https://ncbi.nlm.nih.gov/pubmed/34298713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13143494
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados